Vertex Pharmaceuticals
Focused on the discovery and development of small molecule drugs for the treatment of serious diseases. Learn more
Launch date
Employees
Market cap
€112.3b
Enterprise valuation
€107.9b (Public information from Sep 2024)
Share price
$477.89999 VRTX
Boston Massachusetts (HQ)
Authorizing premium user...